It can be concluded that EAM-2201 has the potential to result in in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, and it is evaluated in pooled human liver microsomes. Summary: Design conversation potentials for genuine elements are frequently optimized with regard to only These experim